Ignite Creation Date:
2025-12-24 @ 5:57 PM
Ignite Modification Date:
2026-02-22 @ 5:22 PM
Study NCT ID:
NCT00513968
Status:
COMPLETED
Last Update Posted:
2012-08-06
First Post:
2007-08-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Study to Investigate the Safety and Efficacy of HBV DNA Vaccine
Sponsor:
Genexine, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
HB110_HB_I
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None